BRIEF published on 03/19/2025 at 12:35, 8 months 17 days ago Décisions du conseil d'administration de Valerio Therapeutics Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
PRESS RELEASE published on 03/19/2025 at 12:30, 8 months 17 days ago Informations privilégiées / Autres communiqués Rapport du conseil d'administration de VALERIO THERAPEUTICS pour l'AG mixte des actionnaires du 9 avril 2025 concernant révocations, cooptations, division du nominal des actions et modifications statutaires Cooptation Revocation Valerio Therapeutics AG Mixte Division Du Nominal
PRESS RELEASE published on 03/19/2025 at 12:30, 8 months 17 days ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 10 months 1 day ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
BRIEF published on 02/04/2025 at 10:40, 10 months 1 day ago Valerio Therapeutics opte pour un recentrage stratégique Innovation Médicale Stratégie Financière Essais Cliniques Oncologie Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 10 months 1 day ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
PRESS RELEASE published on 02/04/2025 at 10:35, 10 months 1 day ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce un recentrage stratégique pour se concentrer sur le développement de médicaments early-stage et assurer une croissance durable. La société cherche un accord de financement à long terme Développement Financement Restructuration Médicaments Valerio Therapeutics
BRIEF published on 10/01/2024 at 00:56, 1 year 2 months ago Valerio Therapeutics publie ses résultats financiers du premier semestre 2024 Résultats Financiers R&D Essai Clinique Valerio Therapeutics Anticorps À Domaine Unique
BRIEF published on 10/01/2024 at 00:56, 1 year 2 months ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
PRESS RELEASE published on 10/01/2024 at 00:51, 1 year 2 months ago Inside Information: News release on accounts, results Valerio Therapeutics annonce ses résultats financiers du Premier Semestre 2024 et fait le point sur ses activités, y compris l'acquisition d'Emglev Therapeutics et le développement de la plateforme PlatONTM Résultats Financiers Biotechnologie Valerio Therapeutics Emglev Therapeutics Plateforme PlatONTM
Published on 12/05/2025 at 17:00, 6 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 6 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 21 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 21 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 31 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 16:25, 41 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 56 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 6 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 6 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 1 hour 6 minutes ago Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 15:10, 1 hour 55 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 55 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 8 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 8 hours 21 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 8 hours 21 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
